Efficacy and safety of edoxaban in patients with chronic thromboembolic pulmonary hypertension: protocol for a multicentre, randomised, warfarin-controlled, parallel group trial - KABUKI trial

INTRODUCTION: Chronic thromboembolic pulmonary hypertension (CTEPH) is a complication of prior pulmonary thromboembolism (PE), caused by incomplete clot dissolution after PE. In patients with CTEPH, lifelong anticoagulation is mandatory to prevent recurrence of PE and secondary in situ thrombus form...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosokawa, Kazuya, Abe, Kohtaro, Kishimoto, Junji, Kobayakawa, Yuko, Todaka, Koji, Tamura, Yuichi, Tatsumi, Koichiro, Inami, Takumi, Ikeda, Nobutaka, Taniguchi, Yu, Minatsuki, Shun, Murohara, Toyoaki, Yasuda, Satoshi, Fukuda, Keiichi, Tsutsui, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301811/
https://www.ncbi.nlm.nih.gov/pubmed/37070473
http://dx.doi.org/10.1136/bmjopen-2022-061225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301811/
https://www.ncbi.nlm.nih.gov/pubmed/37070473
http://dx.doi.org/10.1136/bmjopen-2022-061225

Ejemplares similares